• 0413 - 235 5879
  • drboomi@genomediscovery.org
  • No.101, 12th Cross, Rainbow Nagar, Puducherry-605 001

Combinatorial therapy for gynecologic cancers: A therapeutic mix encompassing Metformin and Navitoclax (ABT-263) (MAN) inhibits the expression of HDAC6, acetylates tumor suppressor proteins, activates tumor suppressor function, and stifles the progression of ARID1A-mutated ovarian cancers, via up-regulation of its target gene, 3/February/2019, 11.22 pm

Scroll Down

"Help us make a difference by supporting our mission with your generous donation."

FOR DONATION

Combinatorial therapy for gynecologic cancers: A therapeutic mix encompassing Metformin and Navitoclax (ABT-263) (MAN) inhibits the expression of HDAC6, acetylates tumor suppressor proteins, activates tumor suppressor function, and stifles the progression of ARID1A-mutated ovarian cancers, via up-regulation of its target gene, 3/February/2019, 11.22 pm

Spread the love
        


Spread the love
        

ABOUT OUR VISITORS

“Website without visitors is like a ship lost in the horizon.”

Page Visits --- 0
Today --- 0
Total ------ 0

"Help us make a difference by supporting our mission with your generous donation."

FOR DONATION
small_c_popup.png

Let's have a chat!

Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!